Full Archive

A different approach

One of the most misunderstood aspects of diabetes management is that 80% of the patients with diabetes are treated by a primary care physician (PCP) and not a specialist. Just to be clear that’s 80% of ALL patients type 1 and type 2, insulin and non-insulin using, intensive and non-intensive management, ok you get the picture. Yet what no one knows is just how much do these PCPs actually know...

Trouble in paradise?

It’s hardly a secret that Dexcom and Abbott are dominating the CGM market. Both companies have held steady with their respective strategies. Dexcom is considered the premium system while Abbott has positioned Libre as the value offering. At the moment Dexcom has one major advantage over Libre as so far none of the Libre systems have been approved to be used with automated insulin delivery (AID) systems. Well according to sources...

The BIG Three

Well here it is ladies and gentlemen the podcast you’ve long been waiting for The Three Amigos, The Sultans of Swat, the Kings of Swing – yep here in one podcast three giants in the world of diabetes – Dr. Satish Garg – Dr. Irl Hirsch and Dr. Steven Edelman – now if you don’t know these three gentlemen Momma Kliff would say shame on you. We should also note...

How it works

Before we begin today this is one of those posts which we give our permission to share. In fact we wish some of you would post it in its entirety as it will serve as a valuable lesson. Lately we’ve seen a resurgence in this belief that insulin companies aren’t investing in developing newer and better insulins. These complaints come mostly from the same folk who also felt insulin cost...

It’s not that complex

The other day while watching CNN they ran a story on rising home prices and then another on falling rents in downtown New York. At the end of the story on home prices the anchor for some reason noted that rising home prices are making home ownership unaffordable for some. Now not sure where this anchor went to school but that’s how capitalism works, when the demand rises and supply...

Time to Un-Load It?

It should shock no one that telehealth investing is setting all sorts of records these days. According to CB Insights investment hit $4.2 Billion in just 139 days nearly doubling the $2.2 Billion raised in the first quarter last year. There is no question that everyone wants in on the act and that investors aren’t that picky in deciding where to place their bets. Yes we have reached that point...

Heavy lifting works

When it comes to digital diabetes there is one indisputable fact, that if you can get the patient to do the heavy lifting you will see improvements in outcomes. As we note continuously the issue isn’t telling the patient how to manage their diabetes, the issue getting the patient to want to manage their diabetes, to do all the heavy lifting. Once that hurdle and it’s a big one has been...